Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Maltecca

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Medical Genetics|March 27, 2019
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activationSusanna Tulli, Andrea Del Bondio, Valentina Baderna, et al.
Archives of Neurology|August 18, 2004
Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutationAmalia C Bruni, Junko Takahashi-Fujigasaki, Francesca Maltecca, et al.
Human Molecular Genetics|May 24, 2017
Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsinEmma J Duncan, Roxanne Larivière, Teisha Y Bradshaw, et al.
BMC Medical Genomics|June 20, 2013
Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathwaysCecilia Mancini, Paola Roncaglia, Alessandro Brussino, et al.
Neurobiology of Disease|November 4, 2018
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicityCecilia Mancini, Eriola Hoxha, Luisa Iommarini, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Medical Genetics|March 27, 2019
Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activationSusanna Tulli, Andrea Del Bondio, Valentina Baderna, et al.
Archives of Neurology|August 18, 2004
Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutationAmalia C Bruni, Junko Takahashi-Fujigasaki, Francesca Maltecca, et al.
Human Molecular Genetics|May 24, 2017
Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsinEmma J Duncan, Roxanne Larivière, Teisha Y Bradshaw, et al.
BMC Medical Genomics|June 20, 2013
Genome-wide expression profiling and functional characterization of SCA28 lymphoblastoid cell lines reveal impairment in cell growth and activation of apoptotic pathwaysCecilia Mancini, Paola Roncaglia, Alessandro Brussino, et al.
Neurobiology of Disease|November 4, 2018
Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicityCecilia Mancini, Eriola Hoxha, Luisa Iommarini, et al.
Pageof 3